We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Imprimis Owes Rival Allergan False Ad Drug Profits, Jury Told

Law360, Santa Ana, Calif. (May 15, 2019, 11:03 PM EDT) -- Imprimis Pharmaceuticals cost competitor Allergan thousands of prescriptions and millions in profits when it lied to consumers that its eye-treatment drugs used FDA-approved ingredients, a California federal jury heard during closing...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

California Central

Nature of Suit

Other Statutory Actions

Judge

Subscribers Only

Date Filed

September 7, 2017

Law Firms

Companies

Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.